why choose us

First received: August 22, 2023

Clinical Trial: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alopecia Areata

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata

Brief Summary: Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss.AA usually affects the head and face, but hair loss can happen on any part of the body.The purpose of this study is to assess how safe, effective, and tolerable upadacitinib is in adolescent and adult participants with severe AA.Upadacitinib is an approved drug being investigated for the treatment of AA.In Study 1 and Study 2 Period A, participants are placed in 1 of 3 groups, called treatment…

Read more